MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+0.94%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$264M
AUM Growth
+$264M
(+34%)
Cap. Flow
+$29.1M
Cap. Flow
% of AUM
11.04%
Top 10 Holdings %
Top 10 Hldgs %
56.06%
Holding
107
New
26
Increased
24
Reduced
19
Closed
16
Top Buys
| 1 |
Patterson-UTI
PTEN
|
$15.9M |
| 2 |
PPTA
Perpetua Resources
PPTA
|
$12.7M |
| 3 |
IAUX
i-80 Gold Corp
IAUX
|
$6.5M |
| 4 |
Capri Holdings
CPRI
|
$6.38M |
| 5 |
Arvinas
ARVN
|
$4.31M |
Top Sells
| 1 |
MAG
MAG Silver
MAG
|
$9.11M |
| 2 |
Pan American Silver
PAAS
|
$7.23M |
| 3 |
PayPal
PYPL
|
$2.94M |
| 4 |
Sprott Physical Silver Trust
PSLV
|
$2.67M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$2.1M |
Sector Composition
| 1 | Healthcare | 29.02% |
| 2 | Materials | 24.37% |
| 3 | Energy | 15.35% |
| 4 | Communication Services | 13.45% |
| 5 | Consumer Discretionary | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nkarta
NKTX
$149M
| $2.63M | 0.46% |
1,583,372
+770,256
| +95% | +$1.28M |
|
27
QuidelOrtho
QDEL
$1.87B
| $2.31M | 0.4% |
80,000
+35,000
| +78% | +$1.01M |
|
28
Stellantis
STLA
$26.4B
| $2.26M | 0.4% |
+225,000
| New | +$2.26M |
|
29
Heron Therapeutics
HRTX
$204M
| $2.24M | 0.39% |
1,080,000
+120,000
| +13% | +$248K |
|
30
Maravai LifeSciences
MRVI
$341M
| $2.12M | 0.37% |
880,965
+45,100
| +5% | +$109K |
|
31
Halliburton
HAL
$18.4B
| $2.04M | 0.36% |
+100,000
| New | +$2.04M |
|
|
MAG
32
MAG Silver
MAG
$2.54B
| $2.01M | 0.35% |
95,000
-431,000
| -82% | -$9.11M |
|
33
Valaris
VAL
$3.49B
| $1.89M | 0.33% |
+45,000
| New | +$1.89M |
|
34
B2Gold
BTG
$5.45B
| $1.81M | 0.32% |
500,000
| – | – |
|
|
35
Teva Pharmaceuticals
TEVA
$21.5B
| $1.68M | 0.29% |
100,000
-125,000
| -56% | -$2.1M |
|
36
Ventyx Biosciences
VTYX
$184M
| $1.63M | 0.29% |
761,891
-372,553
| -33% | -$797K |
|
37
Bunge Global
BG
$16.3B
| $1.61M | 0.28% |
20,000
+16,889
| +543% | +$1.36M |
|
38
Novavax
NVAX
$1.2B
| $1.45M | 0.25% |
230,000
-60,000
| -21% | -$378K |
|
39
Vanda Pharmaceuticals
VNDA
$279M
| $1.44M | 0.25% |
305,000
-20,000
| -6% | -$94.4K |
|
40
Ginkgo Bioworks
DNA
$671M
| $1.41M | 0.25% |
125,000
-52,500
| -30% | -$591K |
|
41
Cytokinetics
CYTK
$5.98B
| $1.4M | 0.25% |
+42,500
| New | +$1.4M |
|
42
Etsy
ETSY
$5.15B
| $1.25M | 0.22% |
+25,000
| New | +$1.25M |
|
43
Inogen
INGN
$213M
| $1.25M | 0.22% |
177,594
+10,000
| +6% | +$70.3K |
|
|
44
Pan American Silver
PAAS
$12.3B
| $1.15M | 0.2% |
40,468
-254,532
| -86% | -$7.23M |
|
45
Nektar Therapeutics
NKTR
$543M
| $1.14M | 0.2% |
43,966
-1,024,933
| -96% | -$705K |
|
46
Intel
INTC
$105B
| $1.12M | 0.2% |
+50,000
| New | +$1.12M |
|
47
Rocket Pharmaceuticals
RCKT
$358M
| $1.11M | 0.19% |
+452,767
| New | +$1.11M |
|
|
MREO
48
Mereo BioPharma
MREO
$275M
| $1.07M | 0.19% |
395,000
-21,468
| -5% | -$58.2K |
|
|
DVS
49
Dolly Varden Silver Corporation
DVS
$342M
| $1.02M | 0.18% |
+305,600
| New | +$1.02M |
|
50
Galapagos
GLPG
$2.06B
| $1.01M | 0.18% |
36,036
| – | – |
|